Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from SeaStar Medical Holding ( (ICU) ) is now available.
SeaStar Medical Holding Corporation, a company involved in the medical industry, had previously entered into an At the Market Offering Agreement with H.C. Wainwright & Co., LLC to sell shares of its common stock. On July 10, 2025, the company decided to suspend and terminate the initial offering but resumed sales on August 8, 2025, with a new aggregate offering price of $2,166,305. The proceeds from these sales are intended for general corporate purposes, and the company retains discretion over their use.
The most recent analyst rating on (ICU) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on SeaStar Medical Holding stock, see the ICU Stock Forecast page.
Spark’s Take on ICU Stock
According to Spark, TipRanks’ AI Analyst, ICU is a Underperform.
SeaStar Medical Holding faces significant financial challenges, with negative equity and reliance on external financing posing risks to its financial health. Technical indicators show bearish momentum, and valuation metrics highlight ongoing losses, contributing to a low overall stock score.
To see Spark’s full report on ICU stock, click here.
More about SeaStar Medical Holding
Average Trading Volume: 7,514,950
Technical Sentiment Signal: Sell
Current Market Cap: $17.77M
Learn more about ICU stock on TipRanks’ Stock Analysis page.